This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.
—Stimulated by the investigation of Alon P. Winnie, MD, of the Abraham Lincoln School of Medicine, Chicago, a total of 27 patients with trigeminal herpes zoster were treated by a bupivacaine (Marcaine) block of the ipsilateral stellate ganglion. Eighteen of these patients were adequately followed up and described by ophthalmologists for comment. All 18 patients received pain relief that ranged from dramatic and lasting relief of all dysesthesia (14 patients) to some discomfort and paresthesia of the affected area persisting for several weeks (four patients). Four patients had recurrence of pain after initial relief. Two patients were re-treated and received lasting pain relief. Of the nine cases of observed iritis, four cleared within six days of the first treatment. Secondary glaucoma followed the course of the iritis. Corneal opacities seemed relatively unaffected by treatment. Vesicular skin lesions dried more quickly than those of previously observed, untreated
Olson ER, Ivy HB. Stellate Block for Trigeminal Herpes Zoster. Arch Ophthalmol. 1980;98(9):1656. doi:10.1001/archopht.1980.01020040508030
Customize your JAMA Network experience by selecting one or more topics from the list below.